Recursion Pharmaceuticals

About:

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Website: https://www.recursion.com

Twitter/X: @RecursionPharma

Top Investors: NVIDIA, National Institutes of Health, Menlo Ventures, Bill & Melinda Gates Foundation, DCVC

Description:

Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to our mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what we believe is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that we use to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate our programs. We are a biotechnology company scaling more like a technology company.

Total Funding Amount:

$865M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Salt Lake City, Utah, United States

Founded Date:

2013-11-05

Contact Email:

info(AT)recursionpharma.com

Hub Tags:

Exited Unicorn

Founders:

Blake Borgeson, Chris Gibson, Dean Li

Number of Employees:

501-1000

Last Funding Date:

2024-06-26

IPO Status:

Public

© 2024 MyAiNote.com